Clinical Trial

Tissue Therapy of Transsphincteric Anal Fistula

Study acronym: REP-PAF
Recruiting Phase 1/2
View on ClinicalTrials.gov →
Summary
This clinical study aims to evaluate the outcome of the treatment of complex perianal fistulas (PAF) by the combination of minimal surgical debridement with regenerative cellular therapeutics.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2024-03-04; most recent amendment 2024-11-02.
Status change: Not Yet Recruiting → Recruiting 2024-11-02
Trial Details
NCT Number NCT06303752
Lead Sponsor University of Southern Denmark
Conditions Anal Fistula
Enrollment 75 participants
Start Date 2024-10-09
Primary Completion 2027-10-08 (estimated)
Study Completion 2028-10-08 (estimated)
Updated on ClinicalTrials.gov 2024-11-05